fluoxetine has been researched along with dynorphins in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, I; Aravich, PF; Lauterio, TJ; Rieg, TS | 1 |
Daunais, JB; Davies, HM; Hart, SL; Hedgecock-Rowe, A; Matasi, JJ; Porrino, LJ; Thornley, C | 1 |
Diaz, J; Lammers, CH; Schwartz, JC; Sokoloff, P | 1 |
Candeletti, S; D'Addario, C; Di Benedetto, M; Izenwasser, S; Romualdi, P | 1 |
Beverley, JA; Carr, B; Steiner, H; Van Waes, V | 1 |
5 other study(ies) available for fluoxetine and dynorphins
Article | Year |
---|---|
Fluoxetine induces vasopressin and oxytocin abnormalities in food-restricted rats given voluntary exercise: relationship to anorexia nervosa.
Topics: Animals; Anorexia Nervosa; Behavior, Animal; Body Weight; Dynorphins; Eating; Fluoxetine; Male; Oxytocin; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Suprachiasmatic Nucleus; Supraoptic Nucleus; Vagus Nerve; Vasopressins | 1993 |
Alterations in behavior and opioid gene expression induced by the novel tropane analog WF-31.
Topics: Animals; Behavior, Animal; Cocaine; Corpus Striatum; Dopamine Uptake Inhibitors; Dynorphins; Enkephalins; Fluoxetine; Gene Expression; Genome; Male; Motor Activity; Protein Precursors; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tropanes | 1997 |
Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Dopamine; Dynorphins; Electroshock; Fluoxetine; Gene Expression; Imipramine; Islands of Calleja; Limbic System; Male; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Substance P; Tranylcypromine | 2000 |
Role of serotonin in the regulation of the dynorphinergic system by a kappa-opioid agonist and cocaine treatment in rat CNS.
Topics: Animals; Benzeneacetamides; Blotting, Northern; Central Nervous System; Cocaine; Dynorphins; Enkephalins; Fluoxetine; Hippocampus; Hypothalamus; Male; Neostriatum; Protein Precursors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA Probes; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin | 2007 |
Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.
Topics: Animals; Autoradiography; Central Nervous System Stimulants; Corpus Striatum; Drug Synergism; Dynorphins; Early Growth Response Protein 1; Enkephalins; Fluoxetine; Gene Expression Regulation; Male; Methylphenidate; Neural Pathways; Neurons; Neuropeptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance P; Substantia Nigra | 2012 |